CLINICAL AND NEUROIMAGING STUDIES IN PATIENTS WITH ACUTE SPONTANEOUS INTRACEREBRAL HEMORRHAGE. by Мaya P. Danovska et al.
/ J of IMAB. 2014, vol. 20, issue 2 / http://www.journal-imab-bg.org 489
CLINICAL AND NEUROIMAGING STUDIES IN
PATIENTS WITH ACUTE SPONTANEOUS IN-
TRACEREBRAL HEMORRHAGE.
Maya P. Danovska1, Margarita L. Alexandrova2, Nachko I. Totsev3, Irena I.
Gencheva4, Plamen G. Stoev1
1) Neurology Clinic, University Hospital - Pleven, Bulgaria
2) Department of Biophysics, Medical University – Pleven, Bulgaria
3) Department of Neuroimaging Studies, University Hospital - Pleven, Bulgaria
4) Medical Diagnostic Clinical Laboratory, University Hospital - Pleven,
Medical University - Pleven, Bulgaria
Journal of IMAB - Annual Proceeding (Scientific Papers) 2014, vol. 20, issue 2 ISSN: 1312-773X (Online)
ABSTRACT
Objective: To define the prognostic value of clini-
cal and neuroimaging parameters on the 30-th day mortal-
ity and clinical outcome after spontaneous intracerebral
hemorrhage (sICH).
Materials and methods: we examined 88 patients
with sICH admitted to Neurology Clinic, UMHAT Pleven
within 48 hours after clinical symptoms onset. Glasgow
Coma Scale (GCS) score was used to assess the primary
stroke severity; neurological deficit on admission was as-
sessed by National Institute of Health Stroke Scale
(NIHSS); clinical outcome at discharge was evaluated by
modified Rankin Scale (mRS) and by Glasgow Outcome
Scale (GOS) on the 30-th day after sICH onset. Hematoma
volume was measured by the formula of Kothari: AxBxC/2
in ml. The statistical analysis was performed by SPSS 19.0
and Statgraphics plus 4.1 for Windows.
Results: Initial assessment of primary stroke sever-
ity and neurological deficit by GCS è NIHSS, hematoma
localization and volume were found strongly correlated
with the clinical outcome on the 30-th day after the sICH
onset. Age and vascular risk factors did not correlate with
the clinical outcome. Male patients had better survival on
the 30-th day compared with the female ones.
Discussion: Neurological deficit on admission,
hematoma localization and volume were found reliable pre-
dictors of the 30-th day clinical outcome that could serve
for early stratification of patients and optimal choice of
therapeutic approach.
Key words: CT, neurological deficit, sICH, clinical
outcome.
INTRODUCTION
Spontaneous intracerebral hemorrhage (sICH) is a
type of stroke usually caused by a vessel rupture followed
by spontaneous leakage of blood in the brain parenchyma
[4]. sICH accounts for only 15-20% of all strokes but is
associated with the highest mortality and disability rate [11,
22]. Despite the achievements of advanced neuroimaging
methods and new therapeutic opportunities of neurovas-
cular intensive care the parameters of sICH morbidity and
mortality remain unchanged [2, 8]. Almost 40% of the pa-
tients die before the 30-th day after sICH, 66% of the sur-
vivors are severely disabled and only 20% recover their
functional independence on the 6-th month after the sICH
[22].
According to the guidelines of ÀÍÀ [American Heart
Association] modern treatment of sICH is mainly support-
ive and is still one of the greatest challenges in the
neurologicall practice [17]. The health and social policy
of some countries, providing easy access to highly quali-
fied medical professionals, effective primary prophylaxis
and control of vascular risk factors, urgent admission to
stroke units with modern intensive care equipment, results
in stable reduction of sICH incidence during the last years
[25, 26].
Unlike ischemic stroke sICH is less investigated in
Bulgaria. There is a substantial lack of population-based
studies on the problems of sICH in our country. No pro-
spective studies, based on the hematoma volume measure-
ment and correlative clinical and neuroimaging analyses
of neurological deficit and clinical outcome are also con-
ducted [3]. An urgent necessity for performing scientific
investigations on sICH arises that could facilitate identifi-
cation of patients with the highest mortality and disabil-
ity risk and offer new therapeutic approaches.
The aim of the present study was to define the pre-
dictive value of some clinical and radiological parameters
for the clinical outcome on the 30-th day after sICH.
MATERIAL AND METHODS
Patients
Of the 337 patients with sICH, admitted to the Neu-
rology Clinic, UMHAT ”Dr. G. Stranski”, Pleven from
March 2005 to July 2010, only 88 (38 males, 50 females,
median age 63.8±11.7 years) were selected on the grounds
of strict exclusion and inclusion criteria. From the study
were excluded patients with hemorrhage due to brain tumor,
trauma, hemorrhagic transformation of ischemic infarction,
rupture of an aneurysm or AVM. No individuals with intra-
ventricular spread of blood or subarachnoidal hemorrhage,
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acute or chronic infections, cancer, kidney and liver dis-
eases or past surgical procedures were included. Patients
with sICH admitted to the clinic after the first 48 hours of
clinical symptoms onset were also excluded from the study.
All experiments were conducted in accordance with the
rules and regulations approved by the University Research
Ethics Committee. Inform consent was obtained by all the
patients or their authorized relatives.
Neurological assessment
A detailed questionnaire assessing the medical his-
tory and physical state of the patients was filled out by a
neurologist. Data regarding demographic and risk factors,
concomitant diseases and treatment, were collected prospec-
tively. Initial stroke severity was assessed by GCS [27], neu-
rological deficit on admission by NIHSS [6]. Functional
outcome at discharge was evaluated by mRS [29] and by
the means of GÎS [13] on the 30-th day after the sICH on-
set. Clinical outcome was defined as a good one for pa-
tients with mRSd”2 è GOS=from 4 to 5 points and as
unfavorable one for those with mRSe”3 and GOS=from 2
to 3 points.
Neuroimaging measurement
Computer tomography scan of the brain was per-
formed on admission with General Electrics Âright Speed
4 - Helical MDCT (Multi Detector Computed Tomography).
Hematoma type, localization and volume were analysed.
According to its localization hematomas were classified as
supratentorial (lobar and basal) and subtentorial.
Hemorrhage volume was measured by a simplified formula
for the volume of an ellipsoid, (AxBxC)/2; where A is the
maximum diameter of the hemorrhage on the CT slice with
the largest area of hemorrhage, B is the maximum diam-
eter 90° to A on the same slice, and C is the number of
axial slices multiplied by the slice thickness [15] (Fig.1).
According to hemorrhage volume hematomas were classi-
fied into: < 30 cm3, from 30 to 60 cm3 and > 60 cm3 [7].
Presence of brain edema, ventricular compression and mid-
line shift were also assessed.
Statistical analysis
Statistical analysis was performed with Statistical
package of Social Sciences SPSS 19.0 and Statgraphics plus
4.1 for Windows. The normality of data was checked with
the Shapiro–Wilk test. The significance of differences be-
tween groups was assessed by Student’s t-test and one-way
ANOVA analysis of variance for normally distributed data,
and by the Mann–Whitney U-test and Kruskal–Wallis test
for non-parametric data. Correlative analysis of Spearman
or Pearson and regression analysis were used to examine
the correlative ratios between the clinical and
neuroimaging parameters according to the type of distri-
bution. Logistic regression was used to assess the prognos-
tic value of statistically significant factors on the depend-
ant variable „outcome on the 30-th day”. A value of p <
0.05 was considered statistically significant.
RESULTS
The basic characteristics and potential factors asso-
ciated with clinical outcome on the 30-th day after the on-
set of sICH are given in Table1. Of all the 88 patients in-
cluded in the study, median age 63.3±14.1 years, 38
(43.2%) were male. According to the medium GOS score -
2.9±1.4 points and mRS score - 5.1±1.5 the clinical out-
come on the 30-th day after sICH was defined as compara-
tively unfavorable. Of 26 (29.5%) patients with lethal out-
come only 7 (26.9%) were male. Arterial hypertension was
found in 81 (92.0%) patients with sICH, diabetes mellitus
had only 7 (8.0%) patients and 23 (26.1%) had Ischemic
Heart Disease (IHD). History of alcohol abuse had 57
(64.8%) patients and smokers were 22 (25%) patients with
sICH. Age, arterial hypertension, systolic blood pressure
(SBP), IHD, diabetes mellitus, alcohol abuse and cigarette
smoking were not statistically significant factors for the
clinical outcome on the 30-th day after sICH.
Male patients showed better clinical outcome com-
pared to female patients (r=0.21, ð=0.04). Higher diastolic
blood pressure (DBP) (p=0.04) was registered in  patients
with poor outcome, compared with the survivors.
Initial assessment of neurological deficit by GCS
and NIHSS was found significantly correlated with lethal
outcome (ð=0.001). Patients with lethal outcome had less
GCS score – 7.2±3.0 compared with the survivors -
11.0±1.8 points, indicating more severe clinical state and
neurological deficit of the patients with lethal outcome (r=-
0.26, p=0.001). Significantly higher score of NIHSS, asso-
ciated with severe neurological deficit had patients with
lethal outcome – 26.0±5.6 points versus those that survived
– 19.0±5.8 points (r=0.31, p=0.001). The severity of neu-
rological deficit, assessed by both scales, appeared to be a
reliable predictor of the clinical outcome on the 30-th day
after sICH. A statistical significance between hematoma
volume and the severity of the neurological deficit assessed
by GCS (Fig.2) è NIHSS (Fig.3) was also found: the increase
of hematoma volume was associated with a lesser score of
GCS and greater score of NIHSS, at 95% and 99% confi-
dential interval.
Multiple logistic regression analysis demonstrated
a possibility of predicting hematoma volume by initial as-
sessment of neurologic deficit with GCS and NIHSS after
the equation: Hematoma volume = 44.4422 +
1.20492*NIHSS - 2.91586*GCS, (ð=0.001).
Of the 78 (88.6%) patients with supratentorial locali-
zation of hematoma, 12 (13.6%) had volume > 60 ml; 30
(34.1%) < 30 ml and almost every second patient (52.3%)
had hematoma volume from 30 to 60 ml. Of all the 26 pa-
tients with lethal outcome (29.5%), 23 (88%) had basal or
thalamic hematoma and only 1 patient (4.0%) with lobar
hematoma died. Patients with the so called  large mixed
hematoma had the highest mortality rate: 6 times greater
was the proportion of patients with lethal outcome (54%),
compared to the survivors (8%) (Fig.4).
Lethal outcome was found strongly correlated with
some of the radiological variables as hematoma localiza-
tion (r=0.47, p=0.001) and volume (r=0.55, p=0.001). Pa-
tients with lethal outcome had twice greater hematoma vol-
ume (1.0±28.0 ml) in comparison with the patients who
survived the 30-th day after sICH (32.7±15.5ml).
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hematoma volume was independent predictor of the clini-
cal outcome on the 30-th day after sICH (OR=1.156,
ð=0.005): the increase of hematoma volume with 1 ml in-
creased the possibility of lethal outcome with 15.6%. The
model had good discrimination ability (ROC area=0.972;
SE=0.023) with optimal sensitivity 90% and specificity -
90%.
Of the 62 (70.5%) survivors, 35.3% were severy disa-
bled, 25% moderately disabled and only 10.2% achieved
functional independence on the 30-th day of sICH. The
leading cause for lethal outcome were concomitant cerebral
and somatic complications in 20.5%, followed by cerebral
complications in 8% and only 1% somatic complications.
Treatment at the clinic lasted 11±3 days according to the
sICH therapeutic algorithm, approved by  the health au-
thorities in our country (minimum 7 days  hospital treat-
ment).
DISCUSSION
Despite the increasing stroke incidence as a result
of world population ageing, sICH still remains an unre-
solved medical problem in modern neurology. The choice
of therapeutic approach is difficult and is mainly domi-
nated by the initial subjective decision of the consulting
neurologist. Treatment is mostly symptomatic, and the
clinical outcome in post-stroke patients is usually poor
with severe disability. There is an urgent necessity for new
experimental and clinical investigations to further clarify
the early objective indicators for the clinical course and
outcome of sICH aiming to optimize the diagnostic and
therapeutic results [5, 9, 20].
Age is an important parameter associated with in-
creased risk for brain hemorrhage morbidity and mortality
[12, 19], but according to our results age did not prove to
be a significant factor for the outcome. The hypothesis that
increased arterial hypertension and SBP, in particular, pre-
dicts hematoma expansion associated with severe neuro-
logic deficit and higher mortality [1, 10, 28], was not con-
firmed by our results. The statistically significant correla-
tion between DBP and poor outcome found in our study
needs further clarification with prospective studies on more
sICH patients. The result that male patients had better out-
come than female ones also needs further study confirma-
tion.
Some clinical parameters indicating the severity of
bleeding, early mortality and poor outcome were identi-
fied on the base of longitudinal study results [11, 14]. We
established significant correlations between the neurologi-
cal deficit, evaluated on admission and hematoma volume.
Such data confirm the clinical significance of GCS and
NIHSS in predicting clinical outcome on the 30-th day af-
ter sICH [11, 14]. Careful analysis of the study results al-
lows promoting GCS and NIHSS feasibility for initial neu-
rological assessment in sICH patients because of their high
level of objectivity and easy performance.
Radiological variables are often used for construct-
ing predictive models as reliable indicators of stroke se-
verity and poor outcome [18, 21, 23, 24]. Some authors [7,
16] define hematoma volume as the key prognostic factor
of sICH outcome. In the present study hematoma volume
was correlated with the neurological deficit assessed by
GCS and NIHSS. The complex analysis of the study results
reveals that hematoma volume and localization influence
significantly clinical outcome on the 30-th day after sICH.
Deep basal and thalamic hemorrhages were found associ-
ated with poor outcome. The greater was the hematoma
volume more severe was the neurological deficit of the pa-
tients. Thus hematoma volume was identified as  independ-
ent predictor of lethal outcome on the 30-th day after sICH.
In conclusion, our study results, despite some limi-
tations, confirm the prognostic value of clinical and
neuroimaging parameters for the 30-th day clinical outcome
after. Complex neurological assessment by the means of
GCS and NIHSS, hematoma volume and localization pro-
vide unique opportunities to neurologists for early and ex-
act prediction of sICH clinical course and outcome, espe-
cially important in three directions: for early stratification
of patients who could improve under intensive care, from
those with suggested poor outcome; in choosing the best
individual therapeutic approach-surgical or conservative
and for better communication with patients and their rela-
tives.
Fig. 1. Calculating hematoma volume after the
method of R. Kothari et al. - AxBxC/ 2 in ml (cm3), where:
1 = A - the maximum diameter of the hemorrhagic lesion;
2 = B - the maximum diameter perpendicular to A; L = C -
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Table 1. Baseline clinical and neuroimaging characteristics associated with clinical outcome on the 30-th day
after sICH.
Parameter Patients with sICH Survivors Patients with P
n=88 n=62 lethalal outcome
n=26
Age [years] 63.8 ± 11.7 64.0 ± 10.7 63.3±14.1 ns
Male sex, n (%) 38 (43.2) 31(50.0) 7 (26.9) 0.04*
 Vascular risk factors
Arterial hypertension, n (%) 81 (92.0) 57 (91.9) 24 (92.3) ns
SBP [mm Hg] 182±31 179±32 188±28 ns
DBP [mm Hg] 102±15 99±15 107±13 0.04*
Ischemic Heart Disease, n (%) 23 (26.1) 14 (22.6) 9 (34.6) ns
Diabetes mellitus, n (%) 7 (8.0) 5 (8.1) 2 (7.7) ns
Alcohol abuse, n (%) 57 (64.8) 42 (67.7) 15 (57.7) ns
Cigarette smoking, n (%) 22 (25.0) 15 (24.2) 7 (26.9) ns
   Neurological examination
GCS on admission [points] 10.0±2.9 11.0.±1.8 7.2±3.0 0.001**
NIHSS on admission [points] 21.3±6.7 19.0±5.8 26.0±5.6 0.001**
GOS on the 30-th day  [points] 2.9±1.4 3.6±0.7 1.0±0 0.001**
mRS at discharge [points] 5.1±1.5   4.3±1.0 7.0±0 0.001**
Radiological variables
Localization, n (%) 0.001**
Medial to the capsule 26 (29.5) 20 (32.3) 6 (23.1)
Lateral to the capsule 23 (26.1) 20 (32.3) 3 (11.5)
Mixed hematoma 19 (21.6) 5 (8.1) 14 (53.8)
Lobar hematoma 10 (11.4) 9 (14.5) 1 (3.8)
Brain stem hematoma 6 (6.8) 4 (6.4) 2 (7.8)
Cerebellar hematoma 4 (4.6) 4 (6.4) 0 (0)
Hematoma volume [ml] 41.0±23.8 32.7 ±15.5 61.0±28.0 0.001**
37.5 (22.5-51.5) 30 (20-42) 52 (42.0-72.0)
Data are presented as median value ±SD or mediana (25 - 75 percentile)
*p<0.05, **p<0.01– statistically significant difference between the patients that survived and those with lethal
outcome on the 30-th day of sICH.
Fig. 2. Correlation between the neuro-
logical deficit assessed with GCS and
hematoma volume (hematoma volume =
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